Report Categories
View AllRecent Articles
View All
ALT Altimmune posts 105 revenue growth but misses Q4 earnings estimates by 102 sparking 675 stock decline
Is Apollo Notes APOS building a durable competitive moat Touches High 20260506
PMTW PennyMac posts 197 percent Q4 2025 EPS upside rises 051 percent on positive investor sentiment
GWH ESS Tech posts steep Q4 2025 EPS miss shares stay flat as investors weigh performance headwinds
Spencer Pratts Social Media Strategy Could Reshape Political Campaigning But Can It Win LA Mayoral Race
Gold Price at Critical Juncture Key Support and Resistance Levels Signal Potential Breakout
Tui Faces Safety Scrutiny After E coli Death of Toddler in Egypt
USChina Trade Rifts Persist at APEC Despite TrumpXi Summit
Trump Signals Iran War Agreement Largely Negotiated Pakistan Officials Cite Encouraging Progress
Satirical Cockroach Party Reports Website Blocked Potential Free Speech and Regulatory Concerns in India
HCWB Q1 2026 Earnings Significant EPS Surprise with No Product Revenue
NOAH Q3 2025 Earnings EPS of 326 Amid Market Headwinds
IMPPP Q1 2026 Earnings Strong EPS Surprise of 644 Exceeds Expectations
CC Q1 2026 Earnings Strong EPS Surprise Despite Unreported Revenue
TSLA Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
GTES Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Demand
AGM Group Holdings AGMH Approaches Key Support After 248 Decline
YD Bio Limited YDES Edges Higher as Support Holds Steady
Silicon Laboratories Inc SLAB Notches Modest Gain Amid Semiconductor Sector Tailwinds
Perdoceo Education PRDO Slips Slightly as Shares Approach Support Zone
Tri Pointe Homes TPH Holds Flat as Traders Eye Support and Resistance Levels
SHG Q1 2026 Earnings EPS Surpasses Estimates Stock Declines Slightly
FNB Q1 2026 Earnings Narrow EPS Miss Offset by Resilient Operations
PLTK Q1 2026 Earnings EPS Misses Estimates by 5181 Amid Challenging Quarter
IMCC Q1 2026 Earnings Loss Per Share Widens Revenue Unreported Stock Gains 298
Kyntra Bio Inc KYNB Q1 2026 Earnings WiderthanExpected Loss Fails to Dampen Investor Sentiment
TNGX Q1 2026 Earnings EPS Misses Consensus as PreRevenue Biotech Advances Pipeline